MI
PFE icon

Motiv8 Investments’s Pfizer PFE Stock Holding History

Motiv8 Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$225 Buy
9,045
+901
+11% +$22.7K 0.12% 95
2025
Q3 		$208K Buy
+8,144
New +$201K 0.11% 90

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Motiv8 Investments's PFE Position: Q4 2025 in Review

Motiv8 Investments increased its Pfizer (PFE) stake by 11% in Q4 2025, buying an estimated $22.7K and bringing the position to 9,045 shares worth $225. The position accounts for 0.12% of the portfolio, ranked #95.

Motiv8 Investments first reported a position in PFE in Q3 2025 and has held it in 2 quarters since. The position peaked at $208K in Q3 2025. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Motiv8 Investments held 9,045 shares of Pfizer worth $225 as of Q4 2025.
  • Motiv8 Investments bought 901 Pfizer shares in Q4 2025, an estimated $22.7K.
  • Pfizer made up 0.12% of Motiv8 Investments's portfolio in Q4 2025, its #95 holding.
  • Motiv8 Investments first reported a position in Pfizer in Q3 2025 and has held it in 2 quarters since.
  • Motiv8 Investments's Pfizer position peaked at $208K in Q3 2025.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.